Concepedia

Michihisa Moriguchi

MM

Statistics

Publications

77

Citations

3.4K

H-Index

34

Active since

2002

Affiliations

Kyoto Prefectural University of Medicine(Current)

Saiseikai Suita Hospital

Shizuoka Cancer Center

National Cancer Center Hospital East

Kindai University

Michihisa Moriguchi is an author at Kyoto Prefectural University of Medicine specializing in medicine, liver disease, and oncology.

ORCID

Publications per year

2002–2025

77

Publications

77

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Thomas Yau, Chiun Hsu, Tae‐You Kim et al. · Journal of Hepatology · 2019 · 269 citations · Full text

, , +17

A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins

Taichiro Nishikawa, Tomoki Nakajima, Michihisa Moriguchi et al. · Journal of Hepatology · 2005 · 180 citations

, , +17

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al. · Liver Cancer · 2022 · 128 citations · Full text

, , +12

The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production

Michihisa Moriguchi, Tomoki Nakajima, Hiroyuki Kimura et al. · International Journal of Cancer · 2002 · 96 citations

, , +11

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

Masatoshi Kudo, Kazuomi Ueshima, Issei Saeki et al. · Liver Cancer · 2023 · 94 citations · Full text

, , +14

1–5 of 77